Form 13-F position report

DYNAVAX TECHNOLOGIES CORP COM

Reported by GEODE CAPITAL MANAGEMENT LLC

DVAX CUSIP 268158201 Manager CIK 0001214717

Reported 2,077,191 shares, up 87,419 (4.4%) from the prior quarter.

Reported value 21.2%; share count 4.4% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 2,077,191 Quarter-end amount reported
Reported value $26,151,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 34833000
2021-12-31 26938000
2022-03-31 21569000
2022-06-30 26151000
2022-09-30 22316000
2022-12-31 23591000
2023-03-31 22700101
2023-06-30 32524816
2023-09-30 39896295
2023-12-31 39440884
2024-03-31 36176936
2024-06-30 34704385
2024-09-30 33425785
2024-12-31 38245932
2025-03-31 39771851
2025-06-30 26675913
2025-09-30 25130153
2025-12-31 37148462
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for DYNAVAX TECHNOLOGIES CORP COM held by GEODE CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -2,415,065 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 2,415,065 -115,338 (-4.6%) < 0.01% $37,148,462 2026-02-09
Q3 2025 Reduced 2,530,403 -158,371 (-5.9%) < 0.01% $25,130,153 2025-11-12
Q2 2025 Reduced 2,688,774 -377,048 (-12.3%) < 0.01% $26,675,913 2025-08-08
Q1 2025 Added 3,065,822 +71,472 (2.4%) < 0.01% $39,771,851 2025-05-13
Q4 2024 Reduced 2,994,350 -5,585 (-0.2%) < 0.01% $38,245,932 2025-02-12
Q3 2024 Reduced 2,999,935 -89,755 (-2.9%) < 0.01% $33,425,785 2024-11-12
Q2 2024 Added 3,089,690 +174,997 (6.0%) < 0.01% $34,704,385 2024-08-09
Q1 2024 Added 2,914,693 +93,795 (3.3%) < 0.01% $36,176,936 2024-05-13
Q4 2023 Added 2,820,898 +120,062 (4.4%) < 0.01% $39,440,884 2024-02-13
Q3 2023 Added 2,700,836 +183,436 (7.3%) < 0.01% $39,896,295 2023-11-13
Q2 2023 Added 2,517,400 +203,425 (8.8%) < 0.01% $32,524,816 2023-08-11
Q1 2023 Added 2,313,975 +96,747 (4.4%) < 0.01% $22,700,101 2023-05-15
Q4 2022 Added 2,217,228 +79,643 (3.7%) < 0.01% $23,591,000 2023-02-13
Q3 2022 Added 2,137,585 +60,394 (2.9%) < 0.01% $22,316,000 2022-11-14
Q2 2022 Added 2,077,191 +87,419 (4.4%) < 0.01% $26,151,000 2022-08-12
Q1 2022 Added 1,989,772 +75,165 (3.9%) < 0.01% $21,569,000 2022-05-13
Q4 2021 Added 1,914,607 +101,297 (5.6%) < 0.01% $26,938,000 2022-02-11
Q3 2021 Added 1,813,310 +46,664 (2.6%) < 0.01% $34,833,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

239 managers reported DYNAVAX TECHNOLOGIES CORP COM for Q2 2022.

Managers reporting DYNAVAX TECHNOLOGIES CORP COM in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 18,561,894 +10,767,432 < 0.01% $233,694,000 31 qtrs
FEDERATED HERMES INC Reduced 16,022,731 -515,107 0.55% $201,726,000 31 qtrs
STATE STREET CORPORATION Added 8,629,427 +130,695 < 0.01% $108,644,000 32 qtrs
Bain Capital Life Sciences Investors LLC Unchanged 8,415,000 0 12.42% $105,945,000 12 qtrs
VANGUARD GROUP INC Added 8,023,967 +2,180,769 < 0.01% $101,023,000 31 qtrs
Chicago Capital LLC Reduced 5,842,906 -12,806 4.06% $73,562,000 18 qtrs
Fisher Asset Management LLC Added 4,288,848 +777,683 0.04% $53,997,000 5 qtrs
PFM Health Sciences LP Unchanged 3,805,370 0 1.83% $47,910,000 9 qtrs
BLAIR WILLIAM & CO IL Reduced 2,525,526 -25,922 0.14% $31,796,000 31 qtrs
EDMOND DE ROTHSCHILD HOLDING S A Reduced 2,320,000 -125,000 0.71% $29,209,000 17 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
2,077,191
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.